This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Inje University. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovating Cancer Treatment: The Contributions of Jongpil Kim
Introduction: Jongpil Kim, a prominent inventor based in Daejeon, South Korea, has made significant strides in the field of cancer treatment through his innovative approaches to gene therapy. With one patent to his name, his work focuses on targeted gene delivery methods that aim to enhance treatment efficacy and patient outcomes.
Latest Patents: Jongpil Kim's patent, titled "Cancer cell targeting gene delivery method," highlights a groundbreaking advancement in cancer therapy. This invention features a chimeric ligand in the form of a fusion polypeptide, which combines a single-chain antibody specific for the Tag-72 surface antigen and the GaLV envelope glycoprotein. The innovative design allows for high transduction efficiency into cancer cells, ensuring that therapeutic genes can be effectively delivered. As a result, this chimeric ligand holds potential for significant improvements in gene therapy by inhibiting tumor growth and metastasis.
Career Highlights: Jongpil Kim is affiliated with Inje University, where his research and developments have contributed to the advancement of medical technology and treatment methodologies. His work in the realm of gene therapy focuses on creating solutions that directly address the challenges posed by cancer cells.
Collaborations: Throughout his career, Jongpil Kim has collaborated with esteemed colleagues, including Yeon-Soo Kim and In Seop So. Their combined expertise supports the research and development efforts in curing cancer, creating a strong foundation for innovative treatment solutions.
Conclusion: Jongpil Kim's commitment to advancing cancer treatment through his inventive gene delivery methods positions him as a key figure in medical research. His patent stands as a testament to the potential of innovative approaches in fighting one of the most challenging diseases of our time. As his work continues to evolve, the contributions of Jongpil Kim will undoubtedly shape the future of cancer therapy and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile